Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Aldosterone excess and essential hypertension

Journal of Human Hypertension volume 16, page 527 (2002)Cite this article

Your recent series of articles1,2,3 on so-called ‘idiopathic hyperaldosteronism’, ‘pseudo-primary hyperaldosteronism’ or ‘non-adenomatous hyperaldosteronism’ revives and perpetuates some very old arguments. Sadly, as Padfield rather patiently indicated,3 much of the present work in the field seems to comprise plodding laboriously once more over ground explored many years ago.

I here draw attention to three relevant observations overlooked by your present writers. Appreciation of those findings could save contemporary workers much trouble.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Connell JMC . Is there an epidemic of primary aldosteronism? J Hum Hypertens 2002; 16: 151–152

    Article  CAS  Google Scholar 

  2. Lim PO, Jung RT, MacDonald TM . Is aldosterone the missing link in refractory hypertension? Aldosterone to renin ratio as a marker of inappropriate aldosterone activity J Hum Hypertens 2002; 16: 153–158

    Article  CAS  Google Scholar 

  3. Padfield PL . Primary aldosteronism, a common entity? The myth persists J Hum Hypertens 2002; 16: 159–162

    Article  CAS  Google Scholar 

  4. Ferriss JB et al. Primary aldosterone excess: Conn's syndrome and similar disorders In: Robertson JIS (ed) Clinical Aspects of Secondary Hypertension. Handbook of Hypertension Vol. 2: Elsevier: Amsterdam 1983; pp 132–161

    Google Scholar 

  5. Fraser R, Lever AF, Brown JJ, Robertson JIS . Cautions over idiopathic aldosteronism Lancet 2001; 358: 332

    Article  CAS  Google Scholar 

  6. McAreavey D, Murray GD, Lever AF, Robertson JIS . Similarity of idiopathic aldosteronism and essential hypertension: a statistical comparison Hypertension 1983; 5: 116–121

    Article  CAS  Google Scholar 

  7. Kremer D et al. Prolonged amiloride therapy in a case of ‘primary’ hyperaldosteronism with chronic peptic ulceration Br Med J 1973; ii: 216–217

    Article  Google Scholar 

  8. Kremer D et al. Spironolactone and amiloride in the treatment of low-renin hyperaldosteronism and related syndromes Clin Sci 1973; 45 (Suppl): 213–218

    Article  Google Scholar 

  9. Kremer D et al. Amiloride in the treatment of primary hyperaldosteronism and essential hypertension Clin End 1977; 7: 151–157

    Article  CAS  Google Scholar 

  10. Ferriss JB et al. The treatment of low-renin (‘primary’) hyperaldosteronism Am Heart J 1978; 96: 97–109

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Elmbank, Manse Road, Bowling, Glasgow G60 5AA, Strathclyde, UK

    J I S Robertson

Authors
  1. J I S Robertson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Robertson, J. Aldosterone excess and essential hypertension. J Hum Hypertens 16, 527 (2002). https://doi.org/10.1038/sj.jhh.1001446

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001446

Search

Advanced search

Quick links